National Healthcare Agreement: PI 68-Proportion of recurrent health expenditure spent on health research and development, 2012

Collection and usage attributes

Health research and development expenditure comprises health research expenditure, undertaken at tertiary institutions, in private non-profit organisations and in government facilities that has a health socio-economic objective, excluding that funded by private business.

Health socio-economic objective is defined by Division 92 in the Socio-economic classification of the 2008 ABS and Statistics New Zealand Australian and New Zealand Standard Research Classification (ABS and Statistics New Zealand 2008), ABS cat. no. 1297.0.

Excludes commercially oriented research carried out or funded by private business, the costs of which are assumed to be included in the prices charged for the goods and services, e.g. medications that have been developed and/or supported by research activities.

Presented as:

2007–08 and 2008–09 (updated as necessary for revised total recurrent health expenditure estimates) and 2009–10—State and territory by source of funding.

Most recent data available for 2012 CRC report: 2009–10.

The AIHW estimates of research expenditure are derived from unpublished ABS data collected in the ABS Surveys of research and experimental development (ABS cat. no. 8111.0, Research and Experimental Development, Higher Education Organisations, Australia, 2006–07 and 2008–09; and ABS cat. no. 8109.0, Research and Experimental Development, Government and Private Non-Profit Organisations, Australia, 2006–07 and 2008–09).

These data are available every two years. For in-between years, the AIHW makes estimates based on interpolation.

Representational attributes

Indicator conceptual framework

Data source attributes

Accountability attributes

Source and reference attributes

Relational attributes